The techniques of evoked responses have been used in the detection of subclinical lesions in optic nerve, spinal cord and brain stem in the diagnosis of multiple sclerosis.' 2 It has become clear that factors other than demyelination can affect the shape and latency of the waveforms. These techniques can be used to probe function in the nervous system rather than be confined to identifying structural abnormalities. Celesia and Daly3 found that the latency of the first negative and the major pcsitive wave of the visual evoked potential (VEP) increased with age. This raises the possibility that the study of VEPs in disorders which were perhaps characterised by accelerated senescence such as Parkinson's disease could be of value. The finding by Schafer and McKean4 that phenylketonuric children have abnormally delayed VEP latencies which become normal upon treatment with a phenylalanine free diet or the addition to the diet of indole and catecholamine precursors suggested that catecholamine played a part in the formation of the evoked potential. Bodis Wollner and Yahr5 demonstrated an abnormally delayed latency of the major positive wave in patients with Parkinson's disease. This delay was shortened in some patients following levodopa therapy indicating that at least some part of the abnormality causing it was amenable to pharmacological manipulation. Their original experiments were performed using a gratAddress for reprint requests: Dr MJ Gawel, Department of Neurology, Charing Cross Hospital, London W6 8RF.
Accepted 20 November 1980 ing as the stimulus but in subsequent experiments they were able to reproduce their findings using a reversing checkerboard. 
Materials and methods
The patients (table 1) were attending the Charing Cross Parkinson's disease clinic of the Department of 227 Neurology. Controls were either the spouses of the patients or other individuals working in the hospital of a suitable age. All subjects had visual acuity equivalent to or better than J4 (corrected), normal visual fields and were free from any ocular disorder. None had a past history of cardiovascular disease or multiple sclerosis. There were 47 patients (mean age 67 yr, age range 51-82, 30 males and 17 females), and 26 controls (mean age 63 yr, age range 40-90, 11 males and 15 females) in the VEP study and 21 patients and 12 controls in the auditory evoked potential (AER) study. Thirteen of the patients in the AER study had also had VEPs. All but 11 of the patients who had VEPs performed were on levodopa therapy and in these the studies were performed as near as possible to two hours after the previous dose. Eleven patients were newly diagnosed and had VEP performed before starting treatment.
VEPs were obtained using a reversing checkerboard stimulus (Digitimer Mark II) giving a luminance of 6-86 cd m-2 for the light squares and 1-46 cd m2 for the dark squares in the centre of the field. Each square was 1 cm square and the patient was positioned 1 metre away. Pattern reversal occurred every 500 ms and the responses were averaged for 96 sweeps in each monocular and binocular stimulation. The recording electrode was in the midline and 5 cm above the inion with the reference 20 cm anterior to it. The potentials obtained were displayed on an oscilloscope screen and the P2 latency was measured automatically using a movable cursor. Amplitudes of the P2 waves were measured from images of the potentials on light sensitive paper with reference to a calibration signal of 10 ,uv. The measurements taken were as follows: Latency P2 was the latency (in ms) from the onset of reversal to the major positive peak (P2). Amplitude A1, was the amplitude from the first negative wave N, to the major positive peak P2. Amplitude A2 was from P2 to the following negative wave N2.
Auditory evoked responses were obtained using a click stimulus 70 db above threshold delivered at the rate of 10/s and averaged over 2000 repetitions. Recordings were from a mastoid electrode placement and the following measurements taken: the latency of the fifth negative wave NV was from the onset of the stimulus to the first negative peak. Amplitude of NV was from NV to the following positive peak. The latency and amplitude of the first negative peak NI was also measured. Results were analysed using Student's t test on individual measurements and a multivariate analysis (RAO) on the amplitudes and latencies of the VEP.
Results (1) VISUAL EVOKED POTENTIALS
These are summarised in tables 1, 2 and 3. Amplitude and latency were different in patients with Parkinson's disease when taken as a group. Com-M J Gawel, P Das, S Vincent, and F Clifford Rose 
